Nationwide study of rates of reinfection with SARS-CoV-2 among adults in Kuwait

Affiliations

26 February 2023

-

doi: 10.26719/emhj.23.015


Abstract

in English, Arabic, French

Background: Data are scarce on differences in the rates of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reinfection after the first infection.

Aims: We examined nationwide data on SARS-CoV-2 reinfection in Kuwait according to four-time windows to reinfection: 29-45 days, 46-60 days, 61-90 days, and ≥ 91 days.

Methods: This was a population-level retrospective cohort study conducted between 31 March 2020 and 31 March 2021. We reviewed evidence of second positive RT-PCR test results for those who had previously recovered from COVID-19 and tested negative.

Results: Reinfection rates were: 0.52% for reinfection window 29-45 days, 0.36% for 45-60 days, 0.29% for 61-90 days, and 0.20% for ≥ 91 days. The mean age (standard deviation [SD]) of individuals with the shortest reinfection time interval (29-45 days) was significantly older than the mean age of all other groups - 43.3 years (SD 17.5) compared with: 39.0 years (SD 16.5), P = 0.037 for 46-60-day interval; 38.3 years (SD 16.5), P = 0.002 for 61-90-day interval; and 39.2 years (SD 14.4), P = 0.001 for ≥ 91-days interval.

Conclusion: SARS-CoV-2 reinfection was uncommon among this adult population. Older age was associated with a shorter time to reinfection.

Keywords: COVID-19; Kuwait; SARS-CoV-2; adults; reinfection.


Similar articles

Incidence of SARS-CoV-2 reinfection in a paediatric cohort in Kuwait.

Alhaddad F, Abdulkareem A, Alsharrah D, Alkandari A, Bin-Hasan S, Al-Ahmad M, Al Hashemi H, Alghounaim M.BMJ Open. 2022 Jun 28;12(6):e056371. doi: 10.1136/bmjopen-2021-056371.PMID: 35768102 Free PMC article.

Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden.

Nordström P, Ballin M, Nordström A.Lancet Infect Dis. 2022 Jun;22(6):781-790. doi: 10.1016/S1473-3099(22)00143-8. Epub 2022 Apr 1.PMID: 35366962 Free PMC article.

Protective effect of a first SARS-CoV-2 infection from reinfection: a matched retrospective cohort study using PCR testing data in England.

Lacy J, Mensah A, Simmons R, Andrews N, Siddiqui MR, Bukasa A, O'Boyle S, Campbell H, Brown K.Epidemiol Infect. 2022 May 24;150:e109. doi: 10.1017/S0950268822000966.PMID: 35607808 Free PMC article.

SARS-CoV-2 reinfection and implications for vaccine development.

Nainu F, Abidin RS, Bahar MA, Frediansyah A, Emran TB, Rabaan AA, Dhama K, Harapan H.Hum Vaccin Immunother. 2020 Dec 1;16(12):3061-3073. doi: 10.1080/21645515.2020.1830683.PMID: 33393854 Free PMC article. Review.

Risk of reinfection and disease after SARS-CoV-2 primary infection: Meta-analysis.

Flacco ME, Acuti Martellucci C, Baccolini V, De Vito C, Renzi E, Villari P, Manzoli L.Eur J Clin Invest. 2022 Oct;52(10):e13845. doi: 10.1111/eci.13845. Epub 2022 Aug 8.PMID: 35904405 Free PMC article. Review.


KMEL References